)
Visual
test
Embla Medical
Embla Medical (EMBLA) investor relations material
Embla Medical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary3 Feb, 2026
Executive summary
Achieved strong organic and acquisition-driven growth in 2025, with notable progress in sustainability, innovation, and expansion into Ukraine.
Rebranded Patient Care facilities to ForMotion in multiple regions, with global completion expected in Q1 2026.
Named to Forbes Accessibility 100 and recognized among the world's top 500 companies for sustainable growth for the second consecutive year.
Navigated significant changes in the operating environment, including tariffs, FX volatility, and geopolitical uncertainty, demonstrating resilience.
Financial highlights
FY 2025 reported sales growth of 9% (6% organic), with Q4 organic growth at 7% and reported growth at 14%.
EBITDA margin was 20% for FY 2025 and 19% in Q4, slightly down year-over-year due to tariffs, FX, and Patient Care initiatives.
Net profit grew 33% in Q4 year-over-year and 21% for FY 2025, reaching USD 84 million.
Gross profit margin was 62% in Q4 and FY 2025, down from 63% in 2024.
Free cash flow reached USD 100 million for FY 2025, the strongest annual cash flow to date.
Outlook and guidance
2026 guidance: organic sales growth of 5-8% and EBITDA margin of 20-22% before special items.
CAPEX expected at 3-4% of sales; effective tax rate projected at 23-24%.
Margin guidance range is wider due to ongoing FX volatility, tariffs, and input cost pressures; tariff costs expected to rise to $8M in 2026.
New share buyback program initiated in January 2026 for up to 2 million shares.
Continued focus on increasing margins and efficiency to offset external pressures.
Quantify Patient Care initiatives' 2026 EBITDA impact
Embla's strategy for US Section 232 tariff risk
Detail US ramp-up for NEURO HITRONIC MPKAFO
Detail 2026 margin guidance external drivers
Patient care: drivers for 2026 margin improvement
Bracing: strategy to overcome structural headwinds
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- TMCV
Q2 FY26 delivered strong growth, margin gains, and record cash flow despite mark-to-market losses. - BMRI
2025 net profit up to Rp61.3T, assets at Rp2,830T, and NIM ranged from 4.59% to 4.89%. - XEL
Ongoing EPS reached $3.80 in 2025; 2026 guidance is $4.04–$4.16 with a $60B capital plan. - EL
Strong Q2 results and raised FY26 outlook, with sales and margins up despite headwinds. - KCR
Record profitability and strong orders in 2025; stable outlook for 2026 amid uncertainties. - 532539
Record Q3 FY26 revenue and profit growth, major expansions, and strong industry outlook. - HAE
Gross margin and net income rose despite lower revenue; guidance for EPS and cash flow increased. - QIGD
Revenue up 18% but net profit down 15% as higher costs and dividends reduced margins and equity. - MYCR
Record annual sales, Q4 order drop, strong Global Technologies, and four acquisitions. - 532548
Revenue up 18.4% YoY, margin gains, and capacity expansions support a positive outlook.
Next Embla Medical earnings date
Q1 202628 Apr, 2026
Embla Medical
Next Embla Medical earnings date
Q1 202628 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Embla Medical hf, formerly known as Össur hf, is an Iceland-based company that operates in the medical equipment and supplies sector. The company specializes in non-invasive prosthetics, medical braces, and support solutions. Its product portfolio includes components for both lower and upper limb prosthetics and various bracing systems designed to assist patients with conditions like osteoarthritis. In addition to product development, Embla Medical also manages a network of patient care clinics that provide personalized mobility solutions and support services. The company's operations extend globally, serving markets across the Americas, Europe, and Asia. Embla Medical is headquartered in Reykjavik, Iceland, and its shares are listed on the Nasdaq Copenhagen.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage